Background and ObjectivesAlzheimer disease (AD) is defined by cortical β-amyloid (Aβ), tau, and neurodegeneration, which contribute to cognitive decline, in part, by altering large-scale functional brain networks. While cortical Aβ and tau have been …
This cohort study evaluates the utility of 3 plasma biomarkers in detecting Alzheimer disease in clinical syndromes related to frontotemporal lobar degeneration.
An abstract is unavailable.
Save the Date: ANNS Annual Meeting! The premier event for neurosurgeons and neurosurgical medical professionals in Boston, April 25-28, 2025.
1 Department of Neurology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, China 2 Department of Geriatrics, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji,…
The landscape of sleep medicine is experiencing swift and profound transformation, driven by rapid advancements in innovation across various fronts, includin…
Background Parkinson’s disease is a progressive neurodegenerative disorder with no cure. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may have neuroprotective effects. However, long-term rea…
In the framework of Rare Disease Day, join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event.
Participate in the open-access Research topic entitled “Theta rhythm generation in learning and memory: cognitive processes and neurological applications”
This cohort study evaluates the utility of 3 plasma biomarkers in detecting Alzheimer disease in clinical syndromes related to frontotemporal lobar degeneration.
